SCHEMBL424408

SCHEMBL424408

COc1cc(C(=O)c2cc3ccc(F)cc3n2C)cc(OC)c1OC

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 18/20 0.51
TUBB P07437 18/20 0.51
TUBA3C P0DPH7 18/20 0.51
TUBA1B P68363 18/20 0.51
TUBA4A P68366 18/20 0.51
TUBB4B P68371 18/20 0.51
TUBB3 Q13509 18/20 0.51
TUBB2A Q13885 18/20 0.51
TUBB8 Q3ZCM7 18/20 0.51
TUBA3E Q6PEY2 18/20 0.51
TUBA1A Q71U36 18/20 0.51
TUBA1C Q9BQE3 18/20 0.51
TUBB6 Q9BUF5 18/20 0.51
TUBB2B Q9BVA1 18/20 0.51
TUBB1 Q9H4B7 18/20 0.51
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428219 0.85 TUBB4A (0.51) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL425795 0.79 TUBB4A (0.53) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL13931839 0.79 MAPT (0.54) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3924468 0.76 L3MBTL1 (0.57) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL29834824 0.76 L3MBTL1 (0.57) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL3920110 0.73 TUBB1 (0.64) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL5744064 0.73 HSD17B10 (0.76) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL29897910 0.73 HSD17B10 (0.76) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL424297 0.72 TUBB4A (0.53) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL425103 0.71 FLT3 (0.60) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR TUBB, TUBB3, TUBB1 TUBB4A 6/4885TUBB 1/4885TUBA3C 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.